Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

887 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Complementary and alternative medicine use among breast cancer survivors.
Matthews AK, Sellergren SA, Huo D, List M, Fleming G. Matthews AK, et al. Among authors: fleming g. J Altern Complement Med. 2007 Jun;13(5):555-62. doi: 10.1089/acm.2007.03-9040. J Altern Complement Med. 2007. PMID: 17604560
Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression.
Poelman SM, Adeyanju MO, Robertson MA, Recant WM, Karrison T, Fleming GF, Olopade OI, Conzen SD. Poelman SM, et al. Among authors: fleming gf. Clin Cancer Res. 2000 Oct;6(10):4043-8. Clin Cancer Res. 2000. PMID: 11051254
A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer.
Laport GG, Fleming GF, Waggoner S, Zimmerman TM, Grinblatt DL, Williams SF. Laport GG, et al. Among authors: fleming gf. Bone Marrow Transplant. 2001 Apr;27(7):677-81. doi: 10.1038/sj.bmt.1702861. Bone Marrow Transplant. 2001. PMID: 11360105 Clinical Trial.
Barriers to clinical trial participation by older women with breast cancer.
Kemeny MM, Peterson BL, Kornblith AB, Muss HB, Wheeler J, Levine E, Bartlett N, Fleming G, Cohen HJ. Kemeny MM, et al. Among authors: fleming g. J Clin Oncol. 2003 Jun 15;21(12):2268-75. doi: 10.1200/JCO.2003.09.124. J Clin Oncol. 2003. PMID: 12805325
Intraperitoneal chemotherapy for ovarian cancer.
Friberg G, Fleming G. Friberg G, et al. Among authors: fleming g. Curr Oncol Rep. 2003 Nov;5(6):447-53. doi: 10.1007/s11912-003-0004-z. Curr Oncol Rep. 2003. PMID: 14521802 Review.
Invariant p53 immunostaining in primary and recurrent breast cancer.
Poelman SM, Heimann R, Fleming GF, Recant WM, Conzen SD. Poelman SM, et al. Among authors: fleming gf. Eur J Cancer. 2004 Jan;40(1):28-32. doi: 10.1016/s0959-8049(03)00661-0. Eur J Cancer. 2004. PMID: 14687786
A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer.
Gupta S, Mauer AM, Ryan CW, Taber DA, Samuels BL, Fleming GF; University of Chicago Phase II Network. Gupta S, et al. Am J Clin Oncol. 2005 Feb;28(1):65-9. doi: 10.1097/01.coc.0000139020.58780.de. Am J Clin Oncol. 2005. PMID: 15685037 Clinical Trial.
Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials.
Kao J, Conzen SD, Jaskowiak NT, Song DH, Recant W, Singh R, Masters GA, Fleming GF, Heimann R. Kao J, et al. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1045-53. doi: 10.1016/j.ijrobp.2004.07.714. Int J Radiat Oncol Biol Phys. 2005. PMID: 15752883 Clinical Trial.
Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804.
Paskett ED, Herndon JE 2nd, Day JM, Stark NN, Winer EP, Grubbs SS, Pavy MD, Shapiro CL, List MA, Hensley ML, Naughton MA, Kornblith AB, Habin KR, Fleming GF, Bittoni MA; Cancer and Leukemia Group B. Paskett ED, et al. Psychooncology. 2008 Nov;17(11):1108-20. doi: 10.1002/pon.1329. Psychooncology. 2008. PMID: 18314912 Free PMC article.
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
Nimeiri HS, Oza AM, Morgan RJ, Friberg G, Kasza K, Faoro L, Salgia R, Stadler WM, Vokes EE, Fleming GF; Chicago Phase II Consortium; PMH Phase II Consortium; California Phase II Consortium. Nimeiri HS, et al. Among authors: fleming gf. Gynecol Oncol. 2008 Jul;110(1):49-55. doi: 10.1016/j.ygyno.2008.02.009. Epub 2008 Apr 18. Gynecol Oncol. 2008. PMID: 18423560 Free PMC article. Clinical Trial.
887 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback